Sopharma AD Statistics

Total Valuation

Sopharma AD has a market cap or net worth of BGN 954.68 million. The enterprise value is 1.35 billion.

Market Cap	954.68M
Enterprise Value	1.35B

Important Dates

The next estimated earnings date is Thursday, January 30, 2025.

Earnings Date	Jan 30, 2025
Ex-Dividend Date	Nov 7, 2024

Share Statistics

Sopharma AD has 165.74 million shares outstanding. The number of shares has increased by 35.46% in one year.

Current Share Class	n/a
Shares Outstanding	165.74M
Shares Change (YoY)	+35.46%
Shares Change (QoQ)	+5.00%
Owned by Insiders (%)	9.17%
Owned by Institutions (%)	4.89%
Float	40.66M

Valuation Ratios

The trailing PE ratio is 12.45.

PE Ratio	12.45
Forward PE	n/a
PS Ratio	0.46
PB Ratio	1.17
P/TBV Ratio	1.32
P/FCF Ratio	8.60
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 9.29, with an EV/FCF ratio of 12.19.

EV / Earnings	16.51
EV / Sales	0.66
EV / EBITDA	9.29
EV / EBIT	12.85
EV / FCF	12.19

Financial Position

The company has a current ratio of 1.43, with a Debt / Equity ratio of 0.49.

Current Ratio	1.43
Quick Ratio	0.70
Debt / Equity	0.49
Debt / EBITDA	3.30
Debt / FCF	3.70
Interest Coverage	6.69

Financial Efficiency

Return on equity (ROE) is 10.95% and return on invested capital (ROIC) is 4.39%.

Return on Equity (ROE)	10.95%
Return on Assets (ROA)	3.48%
Return on Capital (ROIC)	4.39%
Revenue Per Employee	381,996
Profits Per Employee	15,228
Employee Count	4,721
Asset Turnover	1.36
Inventory Turnover	4.48

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.70% in the last 52 weeks. The beta is -0.03, so Sopharma AD's price volatility has been lower than the market average.

Beta (5Y)	-0.03
52-Week Price Change	-2.70%
50-Day Moving Average	5.75
200-Day Moving Average	5.93
Relative Strength Index (RSI)	52.43
Average Volume (20 Days)	9,146

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Sopharma AD had revenue of BGN 2.05 billion and earned 81.91 million in profits. Earnings per share was 0.46.

Revenue	2.05B
Gross Profit	451.40M
Operating Income	83.95M
Pretax Income	95.97M
Net Income	81.91M
EBITDA	117.47M
EBIT	83.95M
Earnings Per Share (EPS)	0.46

Full Income Statement

Balance Sheet

The company has 38.10 million in cash and 410.43 million in debt, giving a net cash position of -372.33 million or -2.25 per share.

Cash & Cash Equivalents	38.10M
Total Debt	410.43M
Net Cash	-372.33M
Net Cash Per Share	-2.25
Equity (Book Value)	841.72M
Book Value Per Share	4.92
Working Capital	249.15M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 137.97 million and capital expenditures -26.98 million, giving a free cash flow of 110.99 million.

Operating Cash Flow	137.97M
Capital Expenditures	-26.98M
Free Cash Flow	110.99M
FCF Per Share	0.67

Full Cash Flow Statement

Margins

Gross margin is 21.97%, with operating and profit margins of 4.09% and 3.99%.

Gross Margin	21.97%
Operating Margin	4.09%
Pretax Margin	4.67%
Profit Margin	3.99%
EBITDA Margin	5.72%
EBIT Margin	4.09%
FCF Margin	5.40%

Dividends & Yields

This stock pays an annual dividend of 0.15, which amounts to a dividend yield of 2.60%.

Dividend Per Share	0.15
Dividend Yield	2.60%
Dividend Growth (YoY)	-89.00%
Years of Dividend Growth	n/a
Payout Ratio	278.20%
Buyback Yield	-35.46%
Shareholder Yield	-32.86%
Earnings Yield	8.03%
FCF Yield	11.63%

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Sopharma AD has an Altman Z-Score of 3.1.

Altman Z-Score	3.1
Piotroski F-Score	n/a